Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy With or Without Bevacizumab in Recurrent or Metastatic Head and Neck Cancer
NCT00588770Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Aug 2008
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of bevacizumab in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Aug 2008; status: active, not recruiting.
02
Drugs
bevacizumab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00588770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588770.